Program Book: Navigating Innovations in Diabetes Care
AMCP is writing to express our serious concerns regarding the inclusion of Section 11, Biological Product Innovation in the FDA and NIH Workforce Authorities Modernization Act (S. 2700)— part of the Senate Innovations legislation marked up in the HELP Committee.
Press Release: Seniors with multiple chronic illnesses who had medications delivered to their homes were more likely to adhere to those therapies than individuals who used retail pharmacies.
Press Release: Patients with high cholesterol should use proven and less expensive therapies, such as statins, before trying the new and more expensive class of specialty cholesterol drugs known as PCSK9 inhibitors.
Press Release: This month's issue of the Journal of Managed Care & Specialty Pharmacy (JMCP) takes an in-depth look at various causes and consequences associated with rising health care costs.
The Academy of Managed Care Pharmacy (AMCP) is pleased to provide general comments and recommendations to the Call for Comments on Endorsement Consideration by PQA Members of a New Performance Measure: Adherence to Long-Acting Inhaled Bronchodilator Agents in COPD Patients.
Program Book: Driving New Advances in Dyslipidemia Management
Partnership Forum: On September 16, 2015, AMCP brought together 50 top executives from large U.S. companies and health plans across the nation for a full day of dialogue on critical issues facing the health care system.
Partnership Forum: Executives from health plans, pharmacy benefit management companies, community and specialty pharmacies and medical societies gathered together in September 2015 to discuss the issues surrounding management of dyslipidemia.
